Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States, with significant operations across Europe, Asia, and other regions. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, the company has established itself as a leader in innovative medicines, particularly in oncology, cardiovascular, and vaccine development. Daiichi Sankyo is renowned for its unique approach to drug discovery and development, leveraging advanced technologies to create targeted therapies. Its core products, including the groundbreaking cancer treatment, have positioned the company as a key competitor in the pharmaceutical market. With a commitment to improving patient outcomes, Daiichi Sankyo continues to achieve notable milestones, solidifying its reputation as a trusted name in healthcare.
DitchCarbon Score
How does Daiichi Sankyo, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Daiichi Sankyo, Inc.'s score of 37 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Daiichi Sankyo, Inc.'s reported carbon emissions
Daiichi Sankyo, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current carbon footprint or progress in addressing climate change. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a broader commitment to environmental responsibility. As such, Daiichi Sankyo may be engaging in internal strategies to align with industry standards, although specific details are not disclosed.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
